Product
High-Dose Quadrivalent Inactivated Influenza Vaccine
1 clinical trial
3 indications
Indication
InfluenzaIndication
Community-acquired PneumoniaIndication
Cardiovascular EventsClinical trial
Relative Vaccine Effectiveness of Adjuvanted Quadrivalent Inactivated Influenza Vaccine vs High-Dose Quadrivalent Inactivated Influenza Vaccine Among Adults ≥65 Years for the 2023-24 and 2024-25 SeasonsStatus: Recruiting, Estimated PCD: 2025-05-01